Centerpoint Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,000
| Closed | -$375K | – | 474 |
|
|
2024
Q1 | $375K | Hold |
27,000
| – | – | 0.14% | 57 |
|
|
2023
Q4 | $385K | Hold |
27,000
| – | – | 0.15% | 55 |
|
|
2023
Q3 | $418K | Hold |
27,000
| – | – | 0.18% | 53 |
|
|
2023
Q2 | $424K | Hold |
27,000
| – | – | 0.17% | 54 |
|
|
2023
Q1 | $445K | Hold |
27,000
| – | – | 0.19% | 49 |
|
|
2022
Q4 | $421K | Hold |
27,000
| – | – | 0.2% | 48 |
|
|
2022
Q3 | $350K | Sell |
27,000
-372
| -1% | -$4.82K | 0.19% | 51 |
|
|
2022
Q2 | $384K | Buy |
27,372
+372
| +1% | +$5.22K | 0.2% | 52 |
|
|
2022
Q1 | $387K | Hold |
27,000
| – | – | 0.18% | 53 |
|
|
2021
Q4 | $368K | Sell |
27,000
-3,700
| -12% | -$50.4K | 0.16% | 59 |
|
|
2021
Q3 | $503K | Hold |
30,700
| – | – | 0.24% | 45 |
|
|
2021
Q2 | $517K | Sell |
30,700
-14,026
| -31% | -$236K | 0.24% | 43 |
|
|
2021
Q1 | $817K | Hold |
44,726
| – | – | 0.48% | 25 |
|
|
2020
Q4 | $814K | Hold |
44,726
| – | – | 0.53% | 25 |
|
|
2020
Q3 | $798K | Hold |
44,726
| – | – | 0.6% | 25 |
|
|
2020
Q2 | $802K | Hold |
44,726
| – | – | 0.65% | 24 |
|
|
2020
Q1 | $679K | Hold |
44,726
| – | – | 0.68% | 23 |
|
|
2019
Q4 | $882K | Buy |
+44,726
| New | +$882K | 0.65% | 21 |
|